
Phoslyra Coupons & Savings Card – Discount Prices from $158.10
My prescription
Edit
473ML of 667MG/5ML, Phoslyra (1 Bottle)
Select pharmacy

CVS
$191.17
COUPON PRICE
Walmart
$158.10
COUPON PRICE
Walgreens
$169.09
COUPON PRICE
Albertsons
$183.57
COUPON PRICEPhoslyra savings card
Show this card to your pharmacist
Walmart
$158.10
BIN
ID
PCN
GRP
019876
LH3865E88D
CHIPPO
LHX
Powered by
Related phosphate binders prescriptions
More prescriptions for kidney disease
Related phosphate binders prescriptions
More prescriptions for kidney disease
Price history for Phoslyra
1 Bottle, 473ML of 667MG/5ML
Average retail price for Phoslyra
Average SaveHealth price for Phoslyra
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Phoslyra dosage forms
Dosage Quantity Price from Per unit 473ML of 667MG/5ML 1 Bottle $158.10 $158.10 473ML of 667MG/5ML 2 Bottles $335.19 $167.59 473ML of 667MG/5ML 3 Bottles $512.28 $170.76
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 473ML of 667MG/5ML | 1 Bottle | $158.10 | $158.10 |
| 473ML of 667MG/5ML | 2 Bottles | $335.19 | $167.59 |
| 473ML of 667MG/5ML | 3 Bottles | $512.28 | $170.76 |
What is PHOSLYRA used for?
Phoslyra is used to control high phosphate levels in patients with chronic kidney disease who are on dialysis. It works by binding to phosphate in the diet so it can be eliminated from the body, helping to prevent complications associated with high phosphate levels.
Was phoslyra discontinued?
Phoslyra has not been discontinued. It is still available as a treatment option for patients who require it.
What is the indication of Phoslyra?
Phoslyra is indicated for the control of serum phosphorus levels in patients with end-stage renal disease (ESRD) who are on dialysis.
